cro.directory
← Compare landing

Fortrea vs Genelife Clinical Research Pvt. Ltd.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryFortreaGenelife Clinical Research Pvt. Ltd.
SummaryFortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs.
Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Clinical Imaging Core Lab
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Japan PMDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Pharmacovigilance & Drug Safety
  • Medical Writing
  • Central Laboratory Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • Small Molecule
  • Biologics (Other)
  • Peptide
  • Vaccine
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
  • Respiratory
  • Dermatology
  • Ophthalmology
  • Gastroenterology
  • Nephrology
  • Women's Health
  • Oncology
  • Neurology
  • Cardiovascular
  • Dermatology
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Real-World Evidence (RWE) / Registries
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Real-World Evidence (RWE) / Registries
Sourcing models
  • Functional Service Provider (FSP)
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Global operations, United States
  • Headquarters, Durham, NC, United States
  • Dallas, Dallas, TX, United States
  • Daytona Beach, Daytona Beach, FL, United States
  • Madison, Madison, WI, United States
  • Sydney, Sydney, NSW, Australia
  • Beijing, Beijing, China
  • Chengdu, Chengdu, Sichuan, China
  • Dalian, Dalian, Liaoning, China
  • Guangzhou, Guangzhou, China
  • Hangzhou, Hangzhou, Zhejiang, China
  • Hong Kong, Hong Kong, China
  • Nanjing, Nanjing, Jiangsu, China
  • Shanghai, Shanghai, China
  • Seoul, Seoul, South Korea
  • Taipei, Taipei, Taiwan
  • Tokyo, Tokyo, Japan
  • Raanana, Raanana, Israel
  • Istanbul, Istanbul, Turkey
  • Bogotá, Bogotá, Colombia
  • Buenos Aires, Buenos Aires, Argentina
  • Lima, Lima, Peru
  • Mexico City, Mexico City, CDMX, Mexico
  • Santiago, Santiago, Chile
  • São Paulo, São Paulo, SP, Brazil
  • Centurion, Centurion, Gauteng, South Africa
  • Clinical Research Unit, Dallas, TX, United States
  • Clinical Research Unit, Daytona Beach, FL, United States
  • Clinical Research Unit, Madison, WI, United States
  • Office, São Paulo, SP, Brazil
  • Office, Mexico City, CDMX, Mexico
  • Office, Buenos Aires, Argentina
  • Office, Santiago, Chile
  • Office, Lima, Peru
  • Office, Bogotá, Colombia
  • Office, Centurion, Gauteng, South Africa
  • Office, Sydney, NSW, Australia
  • Office, Beijing, China
  • Office, Shanghai, China
  • Office, Guangzhou, China
  • Office, Chengdu, Sichuan, China
  • Office, Dalian, Liaoning, China
  • Office, Hangzhou, Zhejiang, China
  • Office, Nanjing, Jiangsu, China
  • Office, Hong Kong, China
  • Office, Tokyo, Japan
  • Office, Seoul, South Korea
  • Office, Taipei, Taiwan
  • Office, Raanana, Israel
  • Office, Istanbul, Turkey
  • Office, Herzliya, Israel
  • Herzliya, Raanana, Israel
  • Herzliya, Herzliya, Israel
  • Office, Hong Kong, Hong Kong
  • Mumbai, India (Headquarters), Mumbai, India
  • Carson, California, Carson, California, USA
  • Cambridge, UK, Cambridge, United Kingdom
  • Hamburg, Germany, Hamburg, Germany
Certifications
  • cGMP · Identifier: In-clinic cGMP Pharmacies
  • FDA · Identifier: cGMP
  • CDSCO · Identifier: CRO/MH/2026/000159

Find similar companies

Fortrea alternatives · Genelife Clinical Research Pvt. Ltd. alternatives

Markdown mirror: /compare/fortrea/genelifecr.md